1. Home
  2. LGND vs MYRG Comparison

LGND vs MYRG Comparison

Compare LGND & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • MYRG
  • Stock Information
  • Founded
  • LGND 1987
  • MYRG 1891
  • Country
  • LGND United States
  • MYRG United States
  • Employees
  • LGND N/A
  • MYRG N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • MYRG Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • LGND Health Care
  • MYRG Industrials
  • Exchange
  • LGND Nasdaq
  • MYRG Nasdaq
  • Market Cap
  • LGND 2.0B
  • MYRG 2.5B
  • IPO Year
  • LGND 1992
  • MYRG N/A
  • Fundamental
  • Price
  • LGND $102.19
  • MYRG $156.85
  • Analyst Decision
  • LGND Strong Buy
  • MYRG Strong Buy
  • Analyst Count
  • LGND 8
  • MYRG 5
  • Target Price
  • LGND $144.71
  • MYRG $152.40
  • AVG Volume (30 Days)
  • LGND 118.3K
  • MYRG 224.8K
  • Earning Date
  • LGND 05-08-2025
  • MYRG 04-30-2025
  • Dividend Yield
  • LGND N/A
  • MYRG N/A
  • EPS Growth
  • LGND N/A
  • MYRG N/A
  • EPS
  • LGND N/A
  • MYRG 2.12
  • Revenue
  • LGND $181,488,000.00
  • MYRG $3,380,348,000.00
  • Revenue This Year
  • LGND $17.68
  • MYRG $5.46
  • Revenue Next Year
  • LGND $18.69
  • MYRG $5.50
  • P/E Ratio
  • LGND N/A
  • MYRG $73.89
  • Revenue Growth
  • LGND 53.40
  • MYRG N/A
  • 52 Week Low
  • LGND $77.43
  • MYRG $86.60
  • 52 Week High
  • LGND $129.90
  • MYRG $168.88
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • MYRG 60.12
  • Support Level
  • LGND $98.90
  • MYRG $154.55
  • Resistance Level
  • LGND $103.17
  • MYRG $162.18
  • Average True Range (ATR)
  • LGND 3.05
  • MYRG 4.19
  • MACD
  • LGND -0.27
  • MYRG -1.86
  • Stochastic Oscillator
  • LGND 31.94
  • MYRG 18.10

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

Share on Social Networks: